Clinical Trials List
Protocol Number1123-0060
Not yet recruiting
2025-12-01 - 2028-06-30
Phase III
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Fu-Yu Lin Division of Neurology
- 林欽揚 Division of Neurology
- Yu Ao Division of Neurology
- Chon-Haw Tsai Division of Neurology
- Hui-Chun Huang Division of Neurology
- 張育嘉 Division of Neurology
- Wei-Shih Huang Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- 黃上芝 Division of Neurology
- Wei-Chung Wang Division of Neurology
- Hung-Yu Huang Division of Neurology
- Yi-Ting Hsu Division of Neurology
- Yuh-Cherng Guo Division of Neurology
- Chung-Hsiang Liu Division of Neurology
- Yi-Chien Yang Division of Neurology
- 許乾盛 Division of Neurology
- Jui-Cheng Chen Division of Neurology
- Kuan-Fei Chen Division of Neurology
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
83 participants
-
Global
1325 participants
